D.a.n.c.e. Therapy Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 19955 Rockside Rd Apt 1507, Bedford Hts, OH 44146 Phone: 216-952-8234 |
Beginning To Heal Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 5311 Northfield Rd, Suite 409, Bedford Hts, OH 44146 Phone: 440-786-8222 Fax: 440-786-7505 |
Brenda Glass Multipurpose Trauma Center Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 24885 Randolph Rd, Bedford Hts, OH 44146 Phone: 440-836-2576 |
Paul J Divincenzo Ph.d Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5311 Northfield Rd, Bedford Hts, OH 44146 Phone: 216-518-3900 |
News Archive
New research has shown that up to 90 per cent of people on asthma medications are using their inhalers incorrectly leading to poor asthma control, increased hospital visits and increased cost of treatment.
A total of 47 people have been infected with Salmonella Kiambu infections from 12 different states as of 21st July 2017, reports the CDC. Of these, 12 have had to be hospitalized and one person from New York City succumbed to the infection. Maradol papayas have been found to be the likely source of this infection and the CDC has recommended people not to consume these until its clear.
Androgen deprivation therapy is a common and effective treatment for advanced prostate cancer. However, among other side-effects, it can cause significant bone thinning in men on long-term treatment.
Psychologists led by Laurent Begue at the Pierre-Mendes France University in the south-eastern city of Grenoble carried out an experiment. In the first stage, 19 drinkers, two-thirds of them men, were asked to assess their attractiveness on a scale of one to seven. Their alcohol levels were measured by a breath analyzer, and as expected, the higher the amount of alcohol that had been drunk, the rosier the self-assessment.
KemPharm, Inc. announced today that it has received a Notice of Issuance from the United States Patent and Trademark Office (USPTO) for its patent application entitled "Polar Hydrophilic Prodrugs of Amphetamine and Other Stimulants and Processes for Making and Using the Same", U.S. Patent No. 7,772,222. This patent protects broad aspects of the Company's core Ligand Activated Therapy (LAT) prodrug technology platform and its application to the treatment of Attention Deficit – Hyperactivity Disorder.
› Verified 8 days ago